[
  {
    "ts": null,
    "headline": "Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones",
    "summary": "TORONTO, September 23, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (\"Cybin\" or the \"Company\"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today highlights significant clinical and regulatory milestones and upcoming value-driving catalysts as the Company advances multiple programs towards potential commercialization.",
    "url": "https://finnhub.io/api/news?id=5bf2a382a78b97de9db5a804699937bdd944f849120e523daf9e4d70cc13826b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758661200,
      "headline": "Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones",
      "id": 136858281,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CBOE",
      "source": "Yahoo",
      "summary": "TORONTO, September 23, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (\"Cybin\" or the \"Company\"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today highlights significant clinical and regulatory milestones and upcoming value-driving catalysts as the Company advances multiple programs towards potential commercialization.",
      "url": "https://finnhub.io/api/news?id=5bf2a382a78b97de9db5a804699937bdd944f849120e523daf9e4d70cc13826b"
    }
  },
  {
    "ts": null,
    "headline": "Transaction in Own Shares",
    "summary": "Transaction in Own Shares 23 September, 2025 • • • • • • • • • • • • • • • •Shell plc (the ‘Company’) announces that on 23 September, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue:Date of purchaseNumber of Shares purchasedHighest price paidLowest price paid Volume weighted average price paid per shareVenueCurrency23/09/2025150,291£26.6200£26.1900£26.3865LSEGBP23/09/2025112,662£26.6200£26.1900£26.3893Chi-X",
    "url": "https://finnhub.io/api/news?id=4d066dd6d8327e95af573c5bb530064c11efb5f4c21571515b887188cefcccc6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758644940,
      "headline": "Transaction in Own Shares",
      "id": 136851768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CBOE",
      "source": "Yahoo",
      "summary": "Transaction in Own Shares 23 September, 2025 • • • • • • • • • • • • • • • •Shell plc (the ‘Company’) announces that on 23 September, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue:Date of purchaseNumber of Shares purchasedHighest price paidLowest price paid Volume weighted average price paid per shareVenueCurrency23/09/2025150,291£26.6200£26.1900£26.3865LSEGBP23/09/2025112,662£26.6200£26.1900£26.3893Chi-X",
      "url": "https://finnhub.io/api/news?id=4d066dd6d8327e95af573c5bb530064c11efb5f4c21571515b887188cefcccc6"
    }
  }
]